Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Hydration Pharmaceuticals CoASX:HPC 3-Year EBITDA Growth Rate is 50.90% as of Dec. 2025, which is 30% above its 10-year median of 39.20. The stock has 3 warning signs investors should review. Among 273 Retail - Defensive companies, The Hydration Pharmaceuticals Co ranks better than 93.41% on this metric.
During the past 3 years, the average EBITDA Per Share Growth Rate was 50.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 5 years, the highest 3-Year average EBITDA Per Share Growth Rate of The Hydration Pharmaceuticals Co was 50.90% per year. The lowest was 27.50% per year. And the median was 39.20% per year.
The Hydration Pharmaceuticals Co (ASX:HPC) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
The Hydration Pharmaceuticals Co 3-Year EBITDA Growth Rate Related Terms
ASX:HPC vs SYY, USFD, PFGC: 3-Year EBITDA Growth Rate Comparison
For the Food Distribution subindustry, The Hydration Pharmaceuticals Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Hydration Pharmaceuticals Co 3-Year EBITDA Growth Rate vs Retail - Defensive Industry
For the Retail - Defensive industry and Consumer Defensive sector, The Hydration Pharmaceuticals Co's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where The Hydration Pharmaceuticals Co's 3-Year EBITDA Growth Rate falls into.
The Hydration Pharmaceuticals Co 3-Year EBITDA Growth Rate Calculation
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 50.90% mean?
The Hydration Pharmaceuticals Co (ASX:HPC) has a 3-Year EBITDA Growth Rate of 50.90% as of Dec. 2025. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for The Hydration Pharmaceuticals Co and its competitors. This is 30% above median its historical median of 39.20. Over the past decade, The Hydration Pharmaceuticals Co's 3-Year EBITDA Growth Rate has ranged from 27.50 to 50.90. According to the industry distribution chart, The Hydration Pharmaceuticals Co ranks #18 out of 273 companies in the Retail - Defensive industry, placing it in the top 6.6%.
Is The Hydration Pharmaceuticals Co's 3-Year EBITDA Growth Rate too high?
The Hydration Pharmaceuticals Co's current 3-Year EBITDA Growth Rate of 50.90% is 30% above median its 10-year median of 39.20. Over the past 10 years, this metric has ranged from a low of 27.50 to a high of 50.90. The Retail - Defensive industry median 3-Year EBITDA Growth Rate is 9.30. The Hydration Pharmaceuticals Co's value of 50.90% is 447.3% above this industry median. Based on the distribution chart, The Hydration Pharmaceuticals Co ranks #18 out of 273 companies in the Retail - Defensive industry, which is in the top quartile — a strong position relative to peers.
How does The Hydration Pharmaceuticals Co's 3-Year EBITDA Growth Rate compare to SYY and USFD?
According to the Retail - Defensive industry distribution chart, The Hydration Pharmaceuticals Co ranks #18 out of 273 companies for 3-Year EBITDA Growth Rate. This places The Hydration Pharmaceuticals Co in the top 7% of its industry — outperforming the majority of peers. The industry median 3-Year EBITDA Growth Rate is 9.30. The Hydration Pharmaceuticals Co's value of 50.90% is 447.3% above this benchmark. Historically, The Hydration Pharmaceuticals Co's own 3-Year EBITDA Growth Rate has ranged from 27.50 to 50.90 over the past decade. While the company's 10-year median is 39.20 vs. the industry median of 9.30, The Hydration Pharmaceuticals Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Retail - Defensive company?
The median 3-Year EBITDA Growth Rate among Retail - Defensive companies is 9.30, based on 273 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. The Hydration Pharmaceuticals Co's current 3-Year EBITDA Growth Rate of 50.90% is 447.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for The Hydration Pharmaceuticals Co and its competitors. For the Retail - Defensive industry, the median 3-Year EBITDA Growth Rate is 9.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Hydration Pharmaceuticals Co's current 3-Year EBITDA Growth Rate is 50.90%, which is 30% above median its own 10-year median of 39.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Hydration Pharmaceuticals Co stock overvalued right now?
The Hydration Pharmaceuticals Co (ASX:HPC) has a current 3-Year EBITDA Growth Rate of 50.90%. The current 3-Year EBITDA Growth Rate is 50.90%, which is 30% above median its 10-year median of 39.20 and 447.3% above the Retail - Defensive industry median of 9.30. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For The Hydration Pharmaceuticals Co (ASX:HPC), the current 3-Year EBITDA Growth Rate is 50.90% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
The Hydration Pharmaceuticals Co Business Description
The Hydration Pharmaceuticals Co Ltd is a consumer products company that markets and sells a range of liquid, tablet and powder Healthy Hydration Solutions products into the USA market, under the Hydralyte brand. Hydralyte collates and translates consumer insights and needs into developing and delivering quality hydration products to market. The Company's business model is an asset light, flexible production model that allows it to outsource manufacturing and packaging to appropriate suppliers.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:HPC has been successfully added to your 
